Safety profile of aromatase inhibitors combined with CDK4/6 inhibitors: a real-world analysis based on FAERS
Abstract Background The combination of a CDK4/6 inhibitor with an aromatase inhibitor (AI) is now a cornerstone first-line treatment. However, the comprehensive safety profile of this combination has not been fully characterized. The aim of this study was to evaluate the real-world safety profile of...
-д хадгалсан:
| Үндсэн зохиолчид: | , , , |
|---|---|
| Формат: | Artigo |
| Хэл сонгох: | Inglês |
| Хэвлэсэн: |
SpringerOpen
2026-05-01
|
| Цуврал: | Future Journal of Pharmaceutical Sciences |
| Нөхцлүүд: | |
| Онлайн хандалт: | https://doi.org/10.1186/s43094-026-00989-6 |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|